medigraphic.com
ISSN 0188-9796 (Impreso)

2007, Número 2

<< Anterior Siguiente >>

Rev Endocrinol Nutr 2007; 15 (2)


Efectos benéficos y deletéreos del consumo de fructosa

Pérez CE, Serralde ZAE, Meléndez MG

Idioma: Español
Referencias bibliográficas: 29
Paginas: 67-74
Archivo PDF: 100.37 Kb.


RESUMEN

La alimentación es un elemento clave del estilo de vida y medio ambiente que influye en la salud y que puede ser controlada. Hoy en día, la obesidad y la diabetes mellitus se han convertido en un problema de salud pública, con una prevalencia que incrementa de forma alarmante. Varias son las explicaciones que se han dado para entender este fenómeno, una de ellas es la asociación con el consumo de fructosa. Pero si este azúcar ha estado presente como parte de nuestra alimentación desde tiempos inmemorables, cabe entonces reflexionar: ¿Cuáles son los factores que han intervenido para que su consumo sea nocivo? Al revisar la evidencia podemos concluir que las alteraciones metabólicas que produce la fructosa no son exclusivos de este azúcar y los efectos que tiene sobre la salud o enfermedad dependen directamente del uso que el ser humano le pueda dar.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. O’Dell B. Fructose and mineral metabolism. Am J Clin Nutr 1993; 58: 771S-778S.

  2. Le KA, Tappy L. Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 2006; 9: 469-475.

  3. Elliott SS, Keim NL, Stern JS, Teff K, Havel P. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002; 76: 911-22.

  4. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr 1993; 58: 754S-765S.

  5. American Dietetic Association. Position of the American Dietetic Association: Use of Nutritive and Nonnutritive Sweeteners. J Am Diet Assoc 2004; 104: 255-275.

  6. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004; 79: 537-543.

  7. Hanover LM, White JS. Manufacturing, composition, and applications of fructose. Am J Clin Nutr 1993; 58: 724S-732S.

  8. Nakagawa T, TuttLe KR, Johnson RJ. Hypothesis: fructose induced hyperuricenia as a casual mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005; (2): 80-86.

  9. Riby JE, Fujisawa T, Kretchmer N. Fructose absorption. Am J Clin Nutr 1993; 58: 748S-753S.

  10. Heather B, Lisa F, Khosrow A. Fructose, insulin resistance, and metabolic dyslipidemia. Nutrition & Metabolism 2005; 2: 5.

  11. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004; 70: 774-779.

  12. Truswell AS, Seach JM, Diet ON, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988; 48: 1424-1430.

  13. Gaby AR. Adverse effects of dietary fructose. Alternative Medicine Review 2005; 10: 294-305.

  14. Rodin J, Reed D, Jamner L. Metabolic effects of fructose and glucose: implications for food intake. Am J Clin Nutr 1988; 47: 683-689.

  15. Gergely P, Tóth B, Farkas I, Bot G. Effect of fructose 1-phosphate on the activation of liver glycogen synthase. Biochem J 1985; 232: 133-137.

  16. Zalitis J, Oliver IT. Inhibition of glucose phosphate isomerase by metabolic intermediates of fructose. Biochem J 1967; 102: 753-759.

  17. Fried SK, Rao SP. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 2003; 78: 873S-880S.

  18. Lee CH, Olson P, Evans RM. Minireview: Lipid metabolism, metabolic disease, and peroxisome proliferatos-activated receptors. Endocrinology 2003; 144: 2201-2207.

  19. Nagai Y, Nishio Y, Nakamura T et al. Amelioration of high fructose-induced metabolic derangements by activation of PPARa. Am J Physiol Endocrinol Metab 2002; 282: E1180-E1190.

  20. Kelly LJ, Vicario PP, Thompson M et al. Peroxisone proliferator-activated receptors g and a mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) Gene expression. Endocrinology 1998; 139: 4920-4927.

  21. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: Opening the X-Files. Science 2001; 294: 1866-1870.

  22. Swanson JE, Laine DC, Thomas W, Bantle J. Metabolic effects of dietary fructose in healthy subjects. Am J Clin Nutr 1992; 55: 851-856.

  23. Reiser S, Powell AS, Yang CHY, Canary JJ. An insulinogenic effect of oral fructose in humans during postprandial hyperglycemia. Am J Clin Nutr 1987; 45: 580-587.

  24. Teff KL, Elliot SS, Tschöp M et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 2004; 89: 2963-2972.

  25. Nakagawa T, Hu H, Zharikov S et al. A causal role for uric acid in fructose induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631.

  26. Holbrook JT, Smith JC Jr, Reiser S. Dietary fructose or starch: effects on copper, zinc, iron, manganese, calcium, and magnesium balances in humans. Am J Clin Nutr 1989; 49: 1290-1294.

  27. Milne DB, Nielsen FH. The interaction between dietary fructose and magnesium adversely affects macromineral homeostasis in men. J Am College Nutr 2000; 19: 31-37.

  28. Nguyen NU, Dumoulin G, Henriet MT, Regnard J. Increase in urinary calcium and oxalate after fructose infusion. Horm Metab Res 1995; 27: 155-158.

  29. Jeffrey W, Nissenbaum, Sclafani A. Qualitative differences in polysaceharide and sugar tastes in the rat: A two-carbohydrate taste model. Neuroscience & Biobehavioral Review 1987; 11: 187-196.




2020     |     www.medigraphic.com